Sichuan Biokin Pharmaceutical Co.,Ltd.

SHSE:688506 Stock Report

Market Cap: CN¥58.4b

Sichuan Biokin PharmaceuticalLtd Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Yi Zhu

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership74.4%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Sichuan Biokin PharmaceuticalLtd (SHSE:688506) Could Easily Take On More Debt

Aug 17
Sichuan Biokin PharmaceuticalLtd (SHSE:688506) Could Easily Take On More Debt

Sichuan Biokin PharmaceuticalLtd's (SHSE:688506) Earnings May Just Be The Starting Point

May 03
Sichuan Biokin PharmaceuticalLtd's (SHSE:688506) Earnings May Just Be The Starting Point

CEO

Yi Zhu (61 yo)

no data

Tenure

CN¥1,120,100

Compensation

Mr. Yi Zhu is Chairman, GM & Chief Scientific Officer of Sichuan Biokin Pharmaceutical Co.,Ltd. Mr. Zhu serves as Chairman, General Manager, Corporate Secretary and Chief Financial Officer of Systimmune, I...